APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dual Orexin Receptor Antagonist Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dual Orexin Receptor Antagonist Tablets Market Outlook and Growth Opportunities 2026

27 December 2025194 pages

Choose your research edition.

Industry ResearchDual Orexin Receptor Antagonist Tablets Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Dual Orexin Receptor Antagonist Tablets Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Dual Orexin Receptor Antagonist Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dual Orexin Receptor Antagonist Tablets Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Dual Orexin Receptor Antagonist Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Dual Orexin Receptor Antagonist Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dual Orexin Receptor Antagonist Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dual Orexin Receptor Antagonist Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dual Orexin Receptor Antagonist Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dual Orexin Receptor Antagonist Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dual Orexin Receptor Antagonist Tablets market include Idorsia, Merck and Eisal, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dual Orexin Receptor Antagonist Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dual Orexin Receptor Antagonist Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dual Orexin Receptor Antagonist Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dual Orexin Receptor Antagonist Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Dual Orexin Receptor Antagonist Tablets Segment by Company

Idorsia

Merck

Eisal

Dual Orexin Receptor Antagonist Tablets Segment by Type

5mg per Tablet

25mg per Tablet

20mg per Tablet

15mg per Tablet

10mg per Tablet

Dual Orexin Receptor Antagonist Tablets Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Dual Orexin Receptor Antagonist Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dual Orexin Receptor Antagonist Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dual Orexin Receptor Antagonist Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dual Orexin Receptor Antagonist Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Dual Orexin Receptor Antagonist Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dual Orexin Receptor Antagonist Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dual Orexin Receptor Antagonist Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dual Orexin Receptor Antagonist Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dual Orexin Receptor Antagonist Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dual Orexin Receptor Antagonist Tablets industry.

Chapter 3: Detailed analysis of Dual Orexin Receptor Antagonist Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dual Orexin Receptor Antagonist Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dual Orexin Receptor Antagonist Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dual Orexin Receptor Antagonist Tablets Industry Trends Table 2. Dual Orexin Receptor Antagonist Tablets Industry Drivers Table 3. Dual Orexin Receptor Antagonist Tablets Industry Opportunities and Challenges Table 4. Dual Orexin Receptor Antagonist Tablets Industry Restraints Table 5. Global Dual Orexin Receptor Antagonist Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dual Orexin Receptor Antagonist Tablets Revenue Share by Company (2021-2026) Table 7. Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Dual Orexin Receptor Antagonist Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Dual Orexin Receptor Antagonist Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Dual Orexin Receptor Antagonist Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dual Orexin Receptor Antagonist Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Dual Orexin Receptor Antagonist Tablets Company, Product Type & Application Table 13. Global Dual Orexin Receptor Antagonist Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dual Orexin Receptor Antagonist Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 5mg per Tablet Table 18. Significant Companies of 25mg per Tablet Table 19. Significant Companies of 20mg per Tablet Table 20. Significant Companies of 15mg per Tablet Table 21. Significant Companies of 10mg per Tablet Table 22. Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Dual Orexin Receptor Antagonist Tablets Sales Volume Share by Type (2021-2026) Table 26. Global Dual Orexin Receptor Antagonist Tablets Sales Volume Share by Type (2027-2032) Table 27. Global Dual Orexin Receptor Antagonist Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Dual Orexin Receptor Antagonist Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Dual Orexin Receptor Antagonist Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type (2021-2026) Table 31. Global Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital and Clinic Table 33. Significant Companies of Retail Pharmacies Table 34. Significant Companies of Other Table 35. Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Dual Orexin Receptor Antagonist Tablets Sales Volume Share by Application (2021-2026) Table 39. Global Dual Orexin Receptor Antagonist Tablets Sales Volume Share by Application (2027-2032) Table 40. Global Dual Orexin Receptor Antagonist Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Dual Orexin Receptor Antagonist Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Dual Orexin Receptor Antagonist Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application (2021-2026) Table 44. Global Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application (2027-2032) Table 45. Global Dual Orexin Receptor Antagonist Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Dual Orexin Receptor Antagonist Tablets Sales by Region (2021-2026) & (K Units) Table 47. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Region (2021-2026) Table 48. Global Dual Orexin Receptor Antagonist Tablets Sales by Region (2027-2032) & (K Units) Table 49. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Region (2027-2032) Table 50. Global Dual Orexin Receptor Antagonist Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Dual Orexin Receptor Antagonist Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Dual Orexin Receptor Antagonist Tablets Sales Value Share by Region (2021-2026) Table 53. Global Dual Orexin Receptor Antagonist Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Dual Orexin Receptor Antagonist Tablets Sales Value Share by Region (2027-2032) Table 55. Global Dual Orexin Receptor Antagonist Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Dual Orexin Receptor Antagonist Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Dual Orexin Receptor Antagonist Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Dual Orexin Receptor Antagonist Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026) & (K Units) Table 60. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Country (2021-2026) Table 61. Global Dual Orexin Receptor Antagonist Tablets Sales by Country (2027-2032) & (K Units) Table 62. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Country (2027-2032) Table 63. Global Dual Orexin Receptor Antagonist Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Dual Orexin Receptor Antagonist Tablets Sales Value Market Share by Country (2021-2026) Table 65. Global Dual Orexin Receptor Antagonist Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Dual Orexin Receptor Antagonist Tablets Sales Value Market Share by Country (2027-2032) Table 67. Idorsia Company Information Table 68. Idorsia Business Overview Table 69. Idorsia Dual Orexin Receptor Antagonist Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Idorsia Dual Orexin Receptor Antagonist Tablets Product Portfolio Table 71. Idorsia Recent Development Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Dual Orexin Receptor Antagonist Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Merck Dual Orexin Receptor Antagonist Tablets Product Portfolio Table 76. Merck Recent Development Table 77. Eisal Company Information Table 78. Eisal Business Overview Table 79. Eisal Dual Orexin Receptor Antagonist Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Eisal Dual Orexin Receptor Antagonist Tablets Product Portfolio Table 81. Eisal Recent Development Table 82. Key Raw Materials Table 83. Raw Materials Key Suppliers Table 84. Dual Orexin Receptor Antagonist Tablets Distributors List Table 85. Dual Orexin Receptor Antagonist Tablets Customers List Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. Dual Orexin Receptor Antagonist Tablets Product Image Figure 2. Global Dual Orexin Receptor Antagonist Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dual Orexin Receptor Antagonist Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dual Orexin Receptor Antagonist Tablets Sales (2021-2032) & (K Units) Figure 5. Global Dual Orexin Receptor Antagonist Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Dual Orexin Receptor Antagonist Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 5mg per Tablet Image Figure 10. 25mg per Tablet Image Figure 11. 20mg per Tablet Image Figure 12. 15mg per Tablet Image Figure 13. 10mg per Tablet Image Figure 14. Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Dual Orexin Receptor Antagonist Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Dual Orexin Receptor Antagonist Tablets Sales Volume Share by Type (2021-2032) Figure 17. Global Dual Orexin Receptor Antagonist Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Dual Orexin Receptor Antagonist Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type (2021-2032) Figure 20. Hospital and Clinic Image Figure 21. Retail Pharmacies Image Figure 22. Other Image Figure 23. Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Dual Orexin Receptor Antagonist Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Dual Orexin Receptor Antagonist Tablets Sales Volume Share by Application (2021-2032) Figure 26. Global Dual Orexin Receptor Antagonist Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Dual Orexin Receptor Antagonist Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application (2021-2032) Figure 29. Global Dual Orexin Receptor Antagonist Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Dual Orexin Receptor Antagonist Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Dual Orexin Receptor Antagonist Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Dual Orexin Receptor Antagonist Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. North America Dual Orexin Receptor Antagonist Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Dual Orexin Receptor Antagonist Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Dual Orexin Receptor Antagonist Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Dual Orexin Receptor Antagonist Tablets Sales Value (2021-2032) & (US$ Million) Figure 40. South America Dual Orexin Receptor Antagonist Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Dual Orexin Receptor Antagonist Tablets Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Dual Orexin Receptor Antagonist Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Dual Orexin Receptor Antagonist Tablets Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Dual Orexin Receptor Antagonist Tablets Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg per Tablet
  • 25mg per Tablet
  • 20mg per Tablet
  • 15mg per Tablet
  • 10mg per Tablet
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Idorsia
  • Merck
  • Eisal

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dual Orexin Receptor Antagonist Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Dual Orexin Receptor Antagonist Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Dual Orexin Receptor Antagonist Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dual Orexin Receptor Antagonist Tablets Market Dynamics
  1. 2.1 Dual Orexin Receptor Antagonist Tablets Industry Trends
  2. 2.2 Dual Orexin Receptor Antagonist Tablets Industry Drivers
  3. 2.3 Dual Orexin Receptor Antagonist Tablets Industry Opportunities and Challenges
  4. 2.4 Dual Orexin Receptor Antagonist Tablets Industry Restraints
3 Dual Orexin Receptor Antagonist Tablets Market by Company
  1. 3.1 Global Dual Orexin Receptor Antagonist Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Dual Orexin Receptor Antagonist Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Dual Orexin Receptor Antagonist Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Dual Orexin Receptor Antagonist Tablets Company Ranking (2024-2026)
  6. 3.6 Global Dual Orexin Receptor Antagonist Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Dual Orexin Receptor Antagonist Tablets Company Product Type and Application
  8. 3.8 Global Dual Orexin Receptor Antagonist Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dual Orexin Receptor Antagonist Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dual Orexin Receptor Antagonist Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dual Orexin Receptor Antagonist Tablets Market by Type
  1. 4.1 Dual Orexin Receptor Antagonist Tablets Type Introduction
  2. 4.1.1 5mg per Tablet
  3. 4.1.2 25mg per Tablet
  4. 4.1.3 20mg per Tablet
  5. 4.1.4 15mg per Tablet
  6. 4.1.5 10mg per Tablet
  7. 4.2 Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Type
  8. 4.2.1 Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Dual Orexin Receptor Antagonist Tablets Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Dual Orexin Receptor Antagonist Tablets Sales Value by Type
  12. 4.3.1 Global Dual Orexin Receptor Antagonist Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Dual Orexin Receptor Antagonist Tablets Sales Value by Type (2021-2032)
  14. 4.3.3 Global Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type (2021-2032)
5 Dual Orexin Receptor Antagonist Tablets Market by Application
  1. 5.1 Dual Orexin Receptor Antagonist Tablets Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Application
  6. 5.2.1 Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dual Orexin Receptor Antagonist Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Dual Orexin Receptor Antagonist Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Dual Orexin Receptor Antagonist Tablets Sales Value by Application
  10. 5.3.1 Global Dual Orexin Receptor Antagonist Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dual Orexin Receptor Antagonist Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application (2021-2032)
6 Dual Orexin Receptor Antagonist Tablets Regional Sales and Value Analysis
  1. 6.1 Global Dual Orexin Receptor Antagonist Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dual Orexin Receptor Antagonist Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Dual Orexin Receptor Antagonist Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Dual Orexin Receptor Antagonist Tablets Sales by Region (2027-2032)
  5. 6.3 Global Dual Orexin Receptor Antagonist Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dual Orexin Receptor Antagonist Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dual Orexin Receptor Antagonist Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dual Orexin Receptor Antagonist Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Dual Orexin Receptor Antagonist Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dual Orexin Receptor Antagonist Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Dual Orexin Receptor Antagonist Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dual Orexin Receptor Antagonist Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Dual Orexin Receptor Antagonist Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dual Orexin Receptor Antagonist Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Dual Orexin Receptor Antagonist Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dual Orexin Receptor Antagonist Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dual Orexin Receptor Antagonist Tablets Sales Value Share by Country, 2025 VS 2032
7 Dual Orexin Receptor Antagonist Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Dual Orexin Receptor Antagonist Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dual Orexin Receptor Antagonist Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Dual Orexin Receptor Antagonist Tablets Sales by Country (2027-2032)
  6. 7.4 Global Dual Orexin Receptor Antagonist Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dual Orexin Receptor Antagonist Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dual Orexin Receptor Antagonist Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dual Orexin Receptor Antagonist Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dual Orexin Receptor Antagonist Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dual Orexin Receptor Antagonist Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Idorsia
  2. 8.1.1 Idorsia Company Information
  3. 8.1.2 Idorsia Business Overview
  4. 8.1.3 Idorsia Dual Orexin Receptor Antagonist Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Idorsia Dual Orexin Receptor Antagonist Tablets Product Portfolio
  6. 8.1.5 Idorsia Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Dual Orexin Receptor Antagonist Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Dual Orexin Receptor Antagonist Tablets Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Eisal
  14. 8.3.1 Eisal Company Information
  15. 8.3.2 Eisal Business Overview
  16. 8.3.3 Eisal Dual Orexin Receptor Antagonist Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Eisal Dual Orexin Receptor Antagonist Tablets Product Portfolio
  18. 8.3.5 Eisal Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dual Orexin Receptor Antagonist Tablets Value Chain Analysis
  2. 9.1.1 Dual Orexin Receptor Antagonist Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dual Orexin Receptor Antagonist Tablets Sales Mode & Process
  6. 9.2 Dual Orexin Receptor Antagonist Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dual Orexin Receptor Antagonist Tablets Distributors
  9. 9.2.3 Dual Orexin Receptor Antagonist Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst